(Q33754811)

29 July 2017

1 reference

title

Psoriasis and the arachidonic acid cascade (English)

1 reference

29 July 2017

Ikai K

1

1 reference

29 July 2017

publication date

1 November 1999

1 reference

Journal of Dermatological Science

29 July 2017

published in

1 reference

29 July 2017

volume

21

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

135-146

1 reference

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Arachidonic acid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Role of eicosanoids in the pathogenesis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

The pathogenesis of chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Eicosanoids in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Properties and regulation of cytosolic phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Inhibition of normal and psoriatic epidermal phospholipase A2 by picomolar concentrations of recombinant human lipocortin I

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Lipocortin I (Annexin I) Is Preferentially Localized on the Plasma Membrane in Keratinocytes of Psoriatic Lesional Epidermis as Shown by Immunofluorescence Microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Immunohistochemical localization of lipocortins in normal and psoriatic human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Characterization and activity of phospholipase A2 in normal human epidermis and in lesion-free epidermis of patients with psoriasis or eczema

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Elevated expression of human nonpancreatic phospholipase A2 in psoriatic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Role of cytosolic phospholipase A2 in allergic response and parturition

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Partial characterization of phospholipase C activity in normal, psoriatic uninvolved, and lesional epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Molecular mechanisms of diverse actions of prostanoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Altered pain perception and inflammatory response in mice lacking prostacyclin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Failure of parturition in mice lacking the prostaglandin F receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Prostaglandin endoperoxide synthase: regulation of enzyme expression

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Prostaglandin D, E, and F synthases

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Characterization and distribution of prostaglandin D synthetase in rat skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Effect of ultraviolet irradiation on the activity of rat skin prostaglandin D synthetase

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

The identification of hydroxy fatty acids in psoriatic skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Proinflammatory properties of unsaturated fatty acids and their monohydroxy metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Inhibitor(s) of prostaglandin synthesis in psoriatic plaque

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

"Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP Cascade" by Voorhees and Duell, October 1971. Commentary: Cyclic adenosine monophosphate regulation of normal and psoriatic epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

A new view of prostaglandin E regulation of the immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Exacerbation of psoriasis induced by indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

1 reference

7 January 2021

5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Polymorphonuclear leukocyte 5-lipoxygenase activity in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Arachidonic acid metabolism by polymorphonuclear leukocytes in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Metabolism of exogenous arachidonic acid by polymorphonuclear leukocytes from psoriatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Biosynthesis of Lipoxygenase Products by Enzyme Preparations from Normal and Psoriatic Skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Expression of 5-lipoxygenase in differentiating human skin keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Human keratinocytes lack the components to produce leukotriene B4

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Altered inflammatory responses in leukotriene-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Leukotriene A4 hydrolase in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Leukotriene A4 hydrolase in peripheral leukocytes of patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Amino-acid sequence and tissue distribution of guinea-pig leukotriene A4 hydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Exacerbation and induction of psoriasis by angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Molecular Cloning of the Gene for Human Leukotriene C Synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

The role of leukotrienes in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Accumulation of leukotriene C4 and histamine in human allergic skin reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Enhanced Synthesis of Cysteinyl Leukotrienes in Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Production of intraepidermal microabscesses by topical application of leukotriene B4

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Delayed-onset synergism between leukotriene B4 and prostaglandin E2 in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Epidermal hyperproliferation following the induction of microabscesses by leukotriene B4.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Identification of Chemotactic Lipoxygenase Products of Arachidonate Metabolism in Psoriatic Skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Chemotactic lipoxygenase products in sera from patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Pustular psoriasis and aseptic purulent arthritis: possible role of leukotrienes B4 and C4 in a flare of synovitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

In vitro synthesis of 12-hydroxy-eicosatetraenoic acid is increased in uninvolved psoriatic epidermis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE).

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Stereochemical difference between 12-hydroxy-5,8,10,14-eicosatetraenoic acid in platelets and psoriatic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

12(R)-hydroxyeicosatetraenoic acid is a neutrophil chemoattractant in the cavine, lapine, murine and canine dermis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Arachidonate 12-lipoxygenases

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

A 12R-lipoxygenase in human skin: mechanistic evidence, molecular cloning, and expression

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Defect of epidermal 12(S)-hydroxyeicosatetraenoic acid receptors in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Occurrence of hepoxilins and trioxilins in psoriatic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Discovery of a second 15S-lipoxygenase in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Eicosanoids in psoriasis--15-HETE on the stage

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

15-hydroxyeicosatetraenoic acid (15-HETE) specifically inhibits the LTB4-induced skin response

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Molecular cloning and functional expression of a phorbol ester-inducible 8S-lipoxygenase from mouse skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Benoxaprofen: effect on cutaneous lesions in psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Benoxaprofen improves psoriasis. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Benoxaprofen does not inhibit formation of leukotriene B4 in a model of acute inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

SC-41930 inhibits neutrophil infiltration of the cavine dermis induced by 12(R)-hydroxyeicosatetraenoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Clinical and Biochemical Effects of an Oral Leukotriene Biosynthesis Inhibitor (MK886) in Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

The fern Polypodium decumanum, used in the treatment of psoriasis, and its fatty acid constituents as inhibitors of leukotriene B4 formation

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Implications of dietary oils and polyunsaturated fatty acids in the management of cutaneous disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Essential fatty acids and the skin

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Fatty acid composition of the plasma lipids in Greenland Eskimos

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Long-term administration of highly purified eicosapentaenoic acid provides improvement of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-1811%2899%2900042-0

7 January 2021

10.1016/S0923-1811(99)00042-0

Identifiers

DOI

1 reference

29 July 2017

1 reference